﻿<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" dtd-version="1.1" specific-use="sps-1.9" article-type="case-report" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">rbof</journal-id>
<journal-title-group>
<journal-title>Revista Brasileira de Oftalmologia</journal-title>
<abbrev-journal-title abbrev-type="publisher">Rev. bras.oftalmol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">0034-7280</issn>
<issn pub-type="epub">1982-8551</issn>
<publisher>
<publisher-name>Sociedade Brasileira de Oftalmologia</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.37039/1982.8551.20260041</article-id>
<article-id pub-id-type="other">01813</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Shamrock sign: a novel indicator of myopia in nuclear cataracts</article-title>
<trans-title-group xml:lang="pt">
<trans-title>Sinal do trevo: um novo indicador de miopia em cataratas nucleares</trans-title>
</trans-title-group>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0000-0001-8756-8114</contrib-id>
<name><surname>Teixeira</surname><given-names>Ivan Corso</given-names></name>
<role>Substantial contribution to conception and design</role>
<role>acquisition of data</role>
<role>analysis and interpretation of data</role>
<role>drafting of the manuscript</role>
<role>critical revision of the manuscript for important intellectual content</role>
<role>final approval of the submitted manuscript</role>
<role>administrative, technical, or material support supervision</role>
<role>research group leadership</role>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0000-0003-4441-4304</contrib-id>
<name><surname>Moscovici</surname><given-names>Bernardo Kaplan</given-names></name>
<role>Substantial contribution to conception and design</role>
<role>analysis and interpretation of data</role>
<role>critical revision of the manuscript for important intellectual content</role>
<role>final approval of the submitted manuscript</role>
<role>research group leadership</role>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c1"/>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0000-0001-6732-0787</contrib-id>
<name><surname>Gondim</surname><given-names>Luís Armando Vitorino Alves de Souza</given-names></name>
<role>Substantial contribution to conception and design</role>
<role>acquisition of data</role>
<role>analysis and interpretation of data</role>
<role>drafting of the manuscript</role>
<role>final approval of the submitted manuscript</role>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0009-0008-9210-5809</contrib-id>
<name><surname>Lucena</surname><given-names>José Maurilio Tavares de</given-names></name>
<role>acquisition of data</role>
<role>drafting of the manuscript</role>
<role>final approval of the submitted manuscript</role>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0000-0003-3927-2129</contrib-id>
<name><surname>Barreto</surname><given-names>Roberta Kern Menna</given-names></name>
<role>acquisition of data</role>
<role>drafting of the manuscript</role>
<role>final approval of the submitted manuscript</role>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0000-0002-9448-8742</contrib-id>
<name><surname>Campos</surname><given-names>Mauro Silveira de Queiroz</given-names></name>
<role>Substantial contribution to conception and design</role>
<role>acquisition of data</role>
<role>analysis and interpretation of data</role>
<role>critical revision of the manuscript for important intellectual content</role>
<role>final approval of the submitted manuscript</role>
<role>research group leadership</role>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<aff id="aff1">
<label>1</label>
<institution content-type="orgname">Hospital de Olhos Paulista</institution>
<addr-line>
<named-content content-type="city">São Paulo</named-content>
<named-content content-type="state">SP</named-content>
</addr-line>
<country country="BR">Brazil</country>
<institution content-type="original">Hospital de Olhos Paulista, São Paulo, SP, Brazil.</institution>
</aff>
<aff id="aff2">
<label>2</label>
<institution content-type="orgname">Universidade Federal de São Paulo</institution>
<institution content-type="orgdiv1">Department of Ophthalmology and Visual Sciences</institution>
<addr-line>
<named-content content-type="city">São Paulo</named-content>
<named-content content-type="state">SP</named-content>
</addr-line>
<country country="BR">Brazil</country>
<institution content-type="original">Department of Ophthalmology and Visual Sciences, Universidade Federal de São Paulo, São Paulo, SP, Brazil.</institution>
</aff>
<aff id="aff3">
<label>3</label>
<institution content-type="orgname">Santa Casa de Misericórdia de São Paulo</institution>
<institution content-type="orgdiv1">Department of Ophthalmology</institution>
<addr-line>
<named-content content-type="city">São Paulo</named-content>
<named-content content-type="state">SP</named-content>
</addr-line>
<country country="BR">Brazil</country>
<institution content-type="original">Department of Ophthalmology, Santa Casa de Misericórdia de São Paulo, São Paulo, SP, Brazil.</institution>
</aff>
</contrib-group>
<author-notes>
<corresp id="c1"><label>Corresponding author:</label> Bernardo Kaplan Moscovici Rua Cayowaá 854 ap 82 CEP <postal-code>05018001</postal-code> <phone>+55 11 996140730</phone> <email>bernardokaplan@yahoo.com.br</email></corresp>
<fn fn-type="coi-statement"><label>Conflict of interest:</label> <p>no conflict of interest.</p></fn>
<fn fn-type="edited-by"><label>Associate editor:</label> <p>Ricardo Augusto Paletta Guedes Universidade Federal de Juiz de Fora, Juiz de Fora, MG, Brazil <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-9451-738X">https://orcid.org/0000-0002-9451-738X</ext-link></p></fn>
</author-notes>
<pub-date publication-format="electronic" date-type="pub">
<day>06</day>
<month>05</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>85</volume>
<elocation-id>e0041</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>10</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>02</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright ©2026</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>The Author(s)</copyright-holder>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
<license-p>All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License</license-p>
</license>
</permissions>
<abstract>
<title>ABSTRACT</title>
<p>This case series presents the shamrock sign, a novel aberrometry pattern characterized by trefoil and coma, as a potential diagnostic marker for nuclear cataracts associated with myopic shift. This study highlights its clinical relevance and contribution to early detection and management. The primary diagnosis was nuclear cataracts inducing myopic shift. All patients underwent phacoemulsification with intraocular lens implantation. Postoperatively, all cases showed marked reductions in higher-order aberrations, including spherical aberration and trefoil, with complete resolution of the shamrock sign. Visual acuity improved significantly, achieving 20/20 in all patients, underscoring the efficacy of surgery in addressing both visual impairment and aberrometry patterns associated with nuclear cataracts. The shamrock sign, identified via aberrometry, may be a reliable diagnostic marker for nuclear cataracts associated with myopia. Its post-surgical resolution underscores its value in guiding clinical decisions and improving diagnostic precision in cataract management.</p>
</abstract>
<trans-abstract xml:lang="pt">
<title>RESUMO</title>
<p>Esta série de casos apresenta o sinal do trevo (<italic>shamrock sign</italic>), um novo padrão em aberrometria caracterizado por trefoil e coma, proposto como possível marcador diagnóstico de catarata nuclear associada a desvio miópico. O estudo destaca sua relevância clínica e contribuição para a detecção precoce e o manejo adequado da condição. O diagnóstico principal foi catarata nuclear induzindo desvio miópico. Todos os pacientes foram submetidos à facoemulsificação com implante de lente intraocular. No pós-operatório, observou-se redução significativa das aberrações de alta ordem – incluindo a aberração esférica e trefoil –, com completa resolução do sinal do trevo. A acuidade visual melhorou expressivamente, atingindo 20/20 em todos os casos, reforçando a eficácia do procedimento, tanto na recuperação visual quanto na normalização dos padrões aberrométricos associados à catarata nuclear. O sinal do trevo, identificado por meio de aberrometria, pode representar um marcador diagnóstico confiável de catarata nuclear associada à miopia. Seu desaparecimento após a cirurgia enfatiza seu valor como ferramenta auxiliar na tomada de decisões clínicas e na maior precisão diagnóstica no manejo da catarata.</p>
</trans-abstract>
<kwd-group xml:lang="en">
<title>Keywords:</title>
<kwd>Cataract</kwd>
<kwd>Myopia</kwd>
<kwd>Aberrometry</kwd>
<kwd>Lens implantation, intraocular</kwd>
<kwd>Phacoemulsification</kwd>
<kwd>Vision disorders</kwd>
<kwd>Visual acuity</kwd>
</kwd-group>
<kwd-group xml:lang="pt">
<title>Descritores:</title>
<kwd>Catarata</kwd>
<kwd>Miopia</kwd>
<kwd>Aberrometria</kwd>
<kwd>Implante de lente intraocular</kwd>
<kwd>Facoemulsificação</kwd>
<kwd>Transtornos da visão</kwd>
<kwd>Acuidade visual</kwd>
</kwd-group>
<funding-group>
<funding-statement><bold>Financial support:</bold> no financial support for this work.</funding-statement>
</funding-group>
<counts>
<fig-count count="2"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="10"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>INTRODUCTION</title>
<p>Cataract remains a predominant cause of blindness worldwide. While myopia is not commonly recognized as a predisposing factor for cataract development, the progression of cataracts, particularly nuclear sclerosis, frequently results in a myopic shift. This myopic shift often precedes cataract formation, especially in patients over the age of 55. However, established clinical signs or objective diagnostic tools to identify nuclear cataracts are limited. <sup>(<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>)</sup></p>
<p>The aberrometry OPD Scan III (Nidek, Tokyo, Japan) is a multifunctional device that measures corneal shape, curvature, and wavefront aberrations. Its reproducibility in measuring high-order aberrations (HOA) is well established. The device is widely used in the pre- and postoperative periods of cataract surgery. <sup>(<xref ref-type="bibr" rid="B3">3</xref>–<xref ref-type="bibr" rid="B6">6</xref>)</sup></p>
<p>The literature reports no signs or diagnostic findings associated with cataract-related myopic shift. We examined three patients diagnosed with nuclear cataracts exhibiting a myopic shift tendency. The internal aberrometry images of all patients showed a consistent pattern of a three-leaf clover, designated as the &quot;shamrock sign&quot; (<xref ref-type="fig" rid="f1">Figure 1</xref>). <sup>(<xref ref-type="bibr" rid="B7">7</xref>–<xref ref-type="bibr" rid="B10">10</xref>)</sup></p>
<fig id="f1">
<label>Figure 1</label>
<caption>
<title>Shamrock sign.</title></caption>
<graphic xlink:href="0034-7280-rbof-85-e0041-gf01.jpg"/>
</fig>
<p>Through detailed case analyses, we aim to emphasize the clinical significance of the shamrock sign as a potential diagnostic marker for nuclear cataracts that induce myopia, even in the very early stages.</p>
<p>Informed consent was obtained from all patients included in this case series, with written authorization for the use of their clinical data and images for research and publication purposes. This study was approved by the Ethics Committee of Hospital de Olhos Paulista, São Paulo, Brazil, under the protocol CAAE number 75264623.0.0000.9867. All procedures adhered to ethical guidelines, ensuring the confidentiality of patient information. Given the nature of this case series, no additional risks were posed to the participants.</p>
</sec>
<sec sec-type="cases">
<title>CASE REPORT</title>
<sec>
<title>Case 1</title>
<p>A 60-year-old male presented with worsening visual acuity (VA) in both eyes. The initial refractive assessment revealed a spherical correction of −10.00 D in the right eye (OD) and −5.25 D in the left eye (OS). Nuclear cataracts were graded as 2+ in OD and 1+ in OS. Visual acuity improved postoperatively, and the shamrock sign was significantly reduced (<xref ref-type="table" rid="t1">Tables 1</xref>–<xref ref-type="table" rid="t3">3</xref> and <xref ref-type="fig" rid="f2">Figure 2</xref>).</p>
<table-wrap id="t1">
<label>Table 1</label>
<caption>
<title>Summary of cases</title></caption>
<table frame="hsides" rules="groups">
<colgroup width="9%">
<col/>
<col/>
<col/>
<col/>
<col/>
<col/>
<col/>
<col/>
<col/>
<col/>
<col/>
</colgroup>
<thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
<tr style="background-color:#124C76;color:#FFFFFF">
<th align="left" valign="middle">Case</th>
<th align="center" valign="middle">Age (years)</th>
<th align="center" valign="middle">Pre-operativeBCVA (OD/OS)</th>
<th align="center" valign="middle">Cataract grade (OD/OS)</th>
<th align="center" valign="middle">Pre-operative HOA total μm (OD/OS)</th>
<th align="center" valign="middle">Pre-operative HOA internal μm (OD/OS)</th>
<th align="center" valign="middle">Pre-operative sphere D (OD/OS)</th>
<th align="center" valign="middle">Post-operative BCVA (OD/OS)</th>
<th align="center" valign="middle">Post-operative HOA μm (OD/OS)</th>
<th align="center" valign="middle">Post-operative HOA internal μm (OD/OS)</th>
<th align="center" valign="middle">Shamrock sign pre (OD/OS)</th>
</tr>
</thead>
<tbody style="border-bottom: thin solid; border-color: #000000">
<tr style="background-color:#EDEDED">
<td align="left" valign="middle">1</td>
<td align="center" valign="middle">60</td>
<td align="center" valign="middle">0.2/0.7</td>
<td align="center" valign="middle">2+/1+</td>
<td align="center" valign="middle">2.060/0.496</td>
<td align="center" valign="middle">2.462/1.032</td>
<td align="center" valign="middle">-10.00/-5.25</td>
<td align="center" valign="middle">1.0/1.0</td>
<td align="center" valign="middle">0.364/0.239</td>
<td align="center" valign="middle">0.257/0.185</td>
<td align="center" valign="middle">Present/Almost present</td>
</tr>
<tr style="background-color:#FDF8D9">
<td align="left" valign="middle">2</td>
<td align="center" valign="middle">42</td>
<td align="center" valign="middle">0.5/0.7</td>
<td align="center" valign="middle">2+/1+</td>
<td align="center" valign="middle">1.304/0.833</td>
<td align="center" valign="middle">1.619/1.024</td>
<td align="center" valign="middle">-8.00/-3.50</td>
<td align="center" valign="middle">1.0/1.0</td>
<td align="center" valign="middle">0.393/0.229</td>
<td align="center" valign="middle">0.317/0.298</td>
<td align="center" valign="middle">Present /Present</td>
</tr>
<tr style="background-color:#EDEDED">
<td align="left" valign="middle">3</td>
<td align="center" valign="middle">55</td>
<td align="center" valign="middle">0.4 /0.5</td>
<td align="center" valign="middle">2+/2+</td>
<td align="center" valign="middle">0.463/0.298</td>
<td align="center" valign="middle">0.495/0.337</td>
<td align="center" valign="middle">-1.50/-1,50</td>
<td align="center" valign="middle">1.0/1.0</td>
<td align="center" valign="middle">0.203/0.152</td>
<td align="center" valign="middle">0.246/0.173</td>
<td align="center" valign="middle">Present/Present</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TFN1">
<p>BCVA: best corrected visual acuity; OD: right eye; OS: left eye; HOA: high-order aberrations.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="t2">
<label>Table 2</label>
<caption>
<title>Internal aberrations in each case</title></caption>
<table frame="hsides" rules="groups">
<colgroup width="12%">
<col/>
<col/>
<col/>
<col/>
<col/>
<col/>
<col/>
<col/>
</colgroup>
<thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
<tr style="background-color:#124C76;color:#FFFFFF">
<th align="left" valign="middle">Case</th>
<th align="center" valign="middle">Eye</th>
<th align="center" valign="middle">Spherical aberration (pre-operative; μm)</th>
<th align="center" valign="middle">Coma (pre-operative; μm)</th>
<th align="center" valign="middle">Trefoil (pre-operative; μm)</th>
<th align="center" valign="middle">Spherical aberration (post-operative; μm)</th>
<th align="center" valign="middle">Coma (post-operative; μm)</th>
<th align="center" valign="middle">Trefoil (post-operative; μm)</th>
</tr>
</thead>
<tbody style="border-bottom: thin solid; border-color: #000000">
<tr style="background-color:#EDEDED">
<td align="left" valign="middle">1</td>
<td align="center" valign="middle">OD</td>
<td align="center" valign="middle">2.112</td>
<td align="center" valign="middle">1.007</td>
<td align="center" valign="middle">0.705</td>
<td align="center" valign="middle">0.170</td>
<td align="center" valign="middle">0.083</td>
<td align="center" valign="middle">0.100</td>
</tr>
<tr style="background-color:#FDF8D9">
<td align="left" valign="middle">1</td>
<td align="center" valign="middle">OS</td>
<td align="center" valign="middle">0.843</td>
<td align="center" valign="middle">0.154</td>
<td align="center" valign="middle">0.503</td>
<td align="center" valign="middle">0.143</td>
<td align="center" valign="middle">0.075</td>
<td align="center" valign="middle">0.065</td>
</tr>
<tr style="background-color:#EDEDED">
<td align="left" valign="middle">2</td>
<td align="center" valign="middle">OD</td>
<td align="center" valign="middle">1.316</td>
<td align="center" valign="middle">0.250</td>
<td align="center" valign="middle">0.866</td>
<td align="center" valign="middle">0.175</td>
<td align="center" valign="middle">0.120</td>
<td align="center" valign="middle">0.042</td>
</tr>
<tr style="background-color:#FDF8D9">
<td align="left" valign="middle">2</td>
<td align="center" valign="middle">OS</td>
<td align="center" valign="middle">0.831</td>
<td align="center" valign="middle">0.205</td>
<td align="center" valign="middle">0.529</td>
<td align="center" valign="middle">0.207</td>
<td align="center" valign="middle">0.154</td>
<td align="center" valign="middle">0.069</td>
</tr>
<tr style="background-color:#EDEDED">
<td align="left" valign="middle">3</td>
<td align="center" valign="middle">OD</td>
<td align="center" valign="middle">0.322</td>
<td align="center" valign="middle">0.270</td>
<td align="center" valign="middle">0.181</td>
<td align="center" valign="middle">0.045</td>
<td align="center" valign="middle">0.085</td>
<td align="center" valign="middle">0.141</td>
</tr>
<tr style="background-color:#FDF8D9">
<td align="left" valign="middle">3</td>
<td align="center" valign="middle">OS</td>
<td align="center" valign="middle">0.249</td>
<td align="center" valign="middle">0.070</td>
<td align="center" valign="middle">0.172</td>
<td align="center" valign="middle">0.079</td>
<td align="center" valign="middle">0.016</td>
<td align="center" valign="middle">0.085 μm</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TFN2">
<p>OD: right eye; OS: left eye.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="t3">
<label>Table 3</label>
<caption>
<title>Aberrometric refraction</title></caption>
<table frame="hsides" rules="groups">
<colgroup width="16%">
<col/>
<col/>
<col/>
<col/>
<col/>
<col/>
</colgroup>
<thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
<tr style="background-color:#124C76;color:#FFFFFF">
<th align="left" valign="middle">Case</th>
<th align="center" valign="middle">Eye</th>
<th align="center" valign="middle">Pre-operative OPD spherical refraction center</th>
<th align="center" valign="middle">Pre-operative OPD spherical refraction total</th>
<th align="center" valign="middle">Pos-operative OPD spherical refraction center</th>
<th align="center" valign="middle">Pos-operative OPD spherical refraction total</th>
</tr>
</thead>
<tbody style="border-bottom: thin solid; border-color: #000000">
<tr style="background-color:#EDEDED">
<td align="left" valign="middle">1</td>
<td align="center" valign="middle">OD</td>
<td align="center" valign="middle">-10.25</td>
<td align="center" valign="middle">-5.00 (7.90mm)</td>
<td align="center" valign="middle">+0.00</td>
<td align="center" valign="middle">-0.25 (5.92 mm)</td>
</tr>
<tr style="background-color:#FDF8D9">
<td align="left" valign="middle">1</td>
<td align="center" valign="middle">OS</td>
<td align="center" valign="middle">-4.75</td>
<td align="center" valign="middle">-4,50 (7.90 mm)</td>
<td align="center" valign="middle">+0.25</td>
<td align="center" valign="middle">-0.50 (5.38mm)</td>
</tr>
<tr style="background-color:#EDEDED">
<td align="left" valign="middle">2</td>
<td align="center" valign="middle">OD</td>
<td align="center" valign="middle">-8.00</td>
<td align="center" valign="middle">-3.00 (6.40mm)</td>
<td align="center" valign="middle">+0.25</td>
<td align="center" valign="middle">+0.00 (5.68 mm)</td>
</tr>
<tr style="background-color:#FDF8D9">
<td align="left" valign="middle">2</td>
<td align="center" valign="middle">OS</td>
<td align="center" valign="middle">-3.50</td>
<td align="center" valign="middle">-0.25 (5.98mm)</td>
<td align="center" valign="middle">+0.00</td>
<td align="center" valign="middle">-0.25 (5.70 mm)</td>
</tr>
<tr style="background-color:#EDEDED">
<td align="left" valign="middle">3</td>
<td align="center" valign="middle">OD</td>
<td align="center" valign="middle">-2.00</td>
<td align="center" valign="middle">+0.25 (4.63mm)</td>
<td align="center" valign="middle">+0.25</td>
<td align="center" valign="middle">+0.25 (4.06mm)</td>
</tr>
<tr style="background-color:#FDF8D9">
<td align="left" valign="middle">3</td>
<td align="center" valign="middle">OS</td>
<td align="center" valign="middle">-2.25</td>
<td align="center" valign="middle">-0.75 (4.67mm)</td>
<td align="center" valign="middle">-0.25</td>
<td align="center" valign="middle">+0.00 (4.28mm)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TFN3">
<p>OD: right eye; OS: left eye.</p></fn>
</table-wrap-foot>
</table-wrap>
<fig id="f2">
<label>Figure 2</label>
<caption>
<title>(A and B): case 1 pre-operative; (C and D): case 1 post-operative; (E and F): case 2 pre-operative; (G and H): case 2 post-operative; (I and J): case 3 pre-operative; (K and L): case 3 post-operative.</title></caption>
<graphic xlink:href="0034-7280-rbof-85-e0041-gf02.jpg"/>
</fig>
</sec>
<sec>
<title>Case 2</title>
<p>A 42-year-old female presented with complaints of decreased VA. The initial refractive examination showed a spherical correction of −8.00 D in OD and −3.50 D in OS. Nuclear cataracts were graded as 2+ in OD and 1+ in OS. Postoperative assessments revealed a reduction in HOAs and the shamrock sign, with VA improving to 1.0 in both eyes.</p>
</sec>
<sec>
<title>Case 3</title>
<p>A 55-year-old male patient presented with complaints of blurred vision in both eyes. Preoperative refraction measurements indicated −1.50 diopters of spherical correction in the right eye and −1.50 diopters of spherical correction with an additional −0.50 cylindrical correction in the left eye. Biomicroscopic examination identified a nuclear cataract graded 2+/4+ in both eyes. The aberrometry exam further revealed the presence of the &quot;shamrock sign&quot; in both eyes, with greater prominence in the left eye. The patient was advised to undergo phacoemulsification in both eyes, with implantation of a multifocal intraocular lens. Following surgery, the shamrock sign markedly reduced, and the patient achieved a UCVA of 1.0 in both eyes.</p>
</sec>
</sec>
<sec sec-type="discussion">
<title>DISCUSSION</title>
<p>The results presented in this case series underscore the significant impact of nuclear cataracts on HOAs and VA. Cases that underwent surgical intervention showed substantial improvements in VA and reductions in the shamrock sign and internal HOAs. <sup>(<xref ref-type="bibr" rid="B1">1</xref>–<xref ref-type="bibr" rid="B3">3</xref>)</sup></p>
<p>The presence of the shamrock sign appears to be associated with more negative spherical refractive values in the central cornea, as indicated by aberrometric measurements. This observation may be attributed to the specific optical configuration induced by nuclear cataracts, in which the progression of nuclear sclerosis increases lens density, disproportionately affecting the central refraction. This finding is particularly relevant in cases in which the shamrock sign was identified, as these cases consistently exhibited more negative central aberrometric refractive values than those in broader regions. <sup>(<xref ref-type="bibr" rid="B4">4</xref>–<xref ref-type="bibr" rid="B7">7</xref>)</sup></p>
<sec>
<title>Comparison between central and total aberrometry refraction</title>
<p>Cases 1 and 2 showed a marked difference between the preoperative central and total spherical refraction. For instance, in case 1, the central spherical refraction in the OD was −10.25D, while the total refraction was −5.00D. This discrepancy can be directly linked to the presence of the shamrock sign, which characterizes aberrations that predominantly affect the optical center. <sup>(<xref ref-type="bibr" rid="B7">7</xref>–<xref ref-type="bibr" rid="B10">10</xref>)</sup></p>
<p>Following surgery, the central spherical refraction in the same eye was corrected to +0.00D, and the total refraction to −0.25D, demonstrating an effective correction of the central aberration induced by the nuclear cataract. Similarly, in case 2, the central spherical refraction in the OD was −8.00D, and the total refraction was −3.00D; both were corrected to approximately +0.25D postoperatively, indicating a notable improvement. <sup>(<xref ref-type="bibr" rid="B1">1</xref>–<xref ref-type="bibr" rid="B3">3</xref>)</sup></p>
<p>The central spherical refraction was also more negative than the total refraction, confirming the impact of the shamrock sign on central refraction. This suggests that surgical decisions could be strongly influenced by evaluating the shamrock sign and central refraction, as correcting these central aberrations can lead to substantial improvements in VA. <sup>(<xref ref-type="bibr" rid="B4">4</xref>–<xref ref-type="bibr" rid="B7">7</xref>)</sup></p>
</sec>
<sec>
<title>High-order aberration analysis</title>
<p>Table 1B provides insight into the specific HOAs in each case, with particular emphasis on spherical aberration, coma, and trefoil, both preoperatively and postoperatively. Comparing these aberrations with the grade of nuclear cataracts or the presence of the shamrock sign reveals notable patterns. <sup>(<xref ref-type="bibr" rid="B1">1</xref>–<xref ref-type="bibr" rid="B3">3</xref>)</sup></p>
<p>Spherical aberration and trefoil were particularly elevated in cases with more advanced nuclear cataracts. For instance, in case 1, the preoperative spherical aberration in the right eye was 2.112 μm, significantly higher than in eyes with less advanced cataracts, such as case 3 (0.322 μm in OD). This correlation suggests that higher grades of nuclear cataract are associated with increased spherical aberration, likely due to the progressive lens opacity that distorts central light transmission. Similarly, trefoil was elevated in cases with more pronounced shamrock sign, suggesting that this aberration may be a marker of the optical irregularities associated with this sign. <sup>(<xref ref-type="bibr" rid="B3">3</xref>–<xref ref-type="bibr" rid="B5">5</xref>)</sup></p>
<p>Postoperatively, there was a marked reduction in both spherical aberration and trefoil, particularly in eyes where the shamrock sign was present preoperatively. For example, in case 1, the spherical aberration in OD decreased from 2.112 μm to 0.170 μm postoperatively, and the trefoil decreased from 0.705 μm to 0.100 μm. This significant reduction underscores the efficacy of cataract surgery in addressing the central optical aberrations associated with nuclear cataracts and the shamrock sign. This case series demonstrated that the shamrock sign was consistently present in all three patients with nuclear cataracts and associated myopic shift. In patients who underwent cataract surgery, there was a significant reduction in the shamrock sign postoperatively, accompanied by an improvement in VA to 1.0. The findings suggest that the shamrock sign could be an important diagnostic marker for nuclear cataracts that induce myopia, potentially aiding in early detection and management.</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure" id="fn1">
<label>Financial support:</label> <p>no financial support for this work.</p></fn>
<fn fn-type="other" id="fn2">
<label>Institution:</label>
<p>Universidade Federal de São Paulo e Hospital de Olhos Paulista, São Paulo, SP, Brasil.</p></fn>
<fn fn-type="other" id="fn3">
<label>Disclosure of Financial and Proprietary Interests:</label> <p>The authors declare that they have no financial or proprietary interests in any material discussed in this article.</p></fn>
<fn fn-type="other" id="fn4">
<label>Disclosure of Public and Private Support:</label> <p>There is nothing to disclose.</p></fn>
</fn-group>
<sec sec-type="data-availability" specific-use="data-available-upon-request">
<title>Data availability:</title> <p>The data that support the findings of this study are not openly available and are available from the corresponding author upon reasonable request. All patients signed informed consent</p>
</sec>
<ref-list>
<title>REFERENCES</title>
<ref id="B1">
<label>1</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name><surname>Nizami</surname><given-names>AA</given-names></name>
<name><surname>Gulani</surname><given-names>AC</given-names></name>
</person-group>
<article-title>Cataract. 2022 Jul 5</article-title>
<source>StatPearls</source>
<publisher-loc>Treasure Island (FL)</publisher-loc>
<publisher-name>StatPearls Publishing</publisher-name>
<year>2023</year>
</element-citation>
<mixed-citation>Nizami AA, Gulani AC. Cataract. 2022 Jul 5. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.</mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Brown</surname><given-names>NA</given-names></name>
<name><surname>Hill</surname><given-names>AR</given-names></name>
</person-group>
<article-title>Cataract: the relation between myopia and cataract morphology</article-title>
<source>Br J Ophthalmol</source>
<year>1987</year>
<volume>71</volume>
<issue>6</issue>
<fpage>405</fpage>
<lpage>414</lpage>
</element-citation>
<mixed-citation>Brown NA, Hill AR. Cataract: the relation between myopia and cataract morphology. Br J Ophthalmol. 1987;71(6):405-14.</mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Asgari</surname><given-names>S</given-names></name>
<name><surname>Hashemi</surname><given-names>H</given-names></name>
<name><surname>Jafarzadehpur</surname><given-names>E</given-names></name>
<name><surname>Mohamadi</surname><given-names>A</given-names></name>
<name><surname>Rezvan</surname><given-names>F</given-names></name>
<name><surname>Fotouhi</surname><given-names>A</given-names></name>
</person-group>
<article-title>OPD-Scan III: a repeatability and inter-device agreement study of a multifunctional device in emmetropia, ametropia, and keratoconus</article-title>
<source>Int Ophthalmol</source>
<year>2016</year>
<volume>36</volume>
<issue>5</issue>
<fpage>697</fpage>
<lpage>705</lpage>
</element-citation>
<mixed-citation>Asgari S, Hashemi H, Jafarzadehpur E, Mohamadi A, Rezvan F, Fotouhi A. OPD-Scan III: a repeatability and inter-device agreement study of a multifunctional device in emmetropia, ametropia, and keratoconus. Int Ophthalmol. 2016;36(5):697-705.</mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Asgari</surname><given-names>S</given-names></name>
<name><surname>Hashemi</surname><given-names>H</given-names></name>
</person-group>
<article-title>OPD scan III accuracy: Topographic and aberrometric indices after accelerated corneal cross-linking</article-title>
<source>J Curr Ophthalmol</source>
<year>2017</year>
<volume>30</volume>
<issue>1</issue>
<fpage>58</fpage>
<lpage>62</lpage>
</element-citation>
<mixed-citation>Asgari S, Hashemi H. OPD scan III accuracy: Topographic and aberrometric indices after accelerated corneal cross-linking. J Curr Ophthalmol. 2017;30(1):58-62.</mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Pathak</surname><given-names>B</given-names></name>
<name><surname>Boruah</surname><given-names>BR</given-names></name>
</person-group>
<article-title>Improvement in error propagation in the Shack-Hartmann-type zonal wavefront sensors</article-title>
<source>J Opt Soc Am A Opt Image Sci Vis</source>
<year>2017</year>
<volume>34</volume>
<issue>12</issue>
<fpage>2194</fpage>
<lpage>2202</lpage>
</element-citation>
<mixed-citation>Pathak B, Boruah BR. Improvement in error propagation in the Shack-Hartmann-type zonal wavefront sensors. J Opt Soc Am A Opt Image Sci Vis. 2017;34(12):2194-202.</mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lafetá Queiroz</surname><given-names>RF</given-names></name>
<name><surname>Kniggendorf</surname><given-names>DV</given-names></name>
<name><surname>de Medeiros</surname><given-names>AL</given-names></name>
<name><surname>Hida</surname><given-names>WT</given-names></name>
<name><surname>Nakano</surname><given-names>CT</given-names></name>
<name><surname>Carricondo</surname><given-names>PC</given-names></name>
<etal/>
</person-group>
<article-title>Clinical comparison of speculum&apos;s influence on intraoperative aberrometry reading</article-title>
<source>Clin Ophthalmol</source>
<year>2019</year>
<volume>13</volume>
<fpage>953</fpage>
<lpage>958</lpage>
</element-citation>
<mixed-citation>Lafetá Queiroz RF, Kniggendorf DV, de Medeiros AL, Hida WT, Nakano CT, Carricondo PC, et al. Clinical comparison of speculum&apos;s influence on intraoperative aberrometry reading. Clin Ophthalmol. 2019;13:953-8.</mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Cruz</surname><given-names>JC</given-names></name>
<name><surname>Moreno</surname><given-names>CB</given-names></name>
<name><surname>Soares</surname><given-names>PV</given-names></name>
<name><surname>Moscovici</surname><given-names>BK</given-names></name>
<name><surname>Colombo-Barboza</surname><given-names>GN</given-names></name>
<name><surname>Colombo-Barboza</surname><given-names>LR</given-names></name>
<etal/>
</person-group>
<article-title>Comparison of endothelial cell loss in diabetic patients after conventional phacoemulsification and femtosecond laser-assisted cataract surgery</article-title>
<source>BMC Ophthalmol</source>
<year>2023</year>
<volume>23</volume>
<issue>1</issue>
<fpage>181</fpage>
<lpage>181</lpage>
</element-citation>
<mixed-citation>Cruz JC, Moreno CB, Soares PV, Moscovici BK, Colombo-Barboza GN, Colombo-Barboza LR, et al. Comparison of endothelial cell loss in diabetic patients after conventional phacoemulsification and femtosecond laser-assisted cataract surgery. BMC Ophthalmol. 2023;23(1):181.</mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rios</surname><given-names>LC</given-names></name>
<name><surname>Silva</surname><given-names>PG</given-names></name>
<name><surname>Canamary</surname><given-names>AM</given-names><suffix>Júnior</suffix></name>
<name><surname>Rodrigues</surname><given-names>P</given-names></name>
<name><surname>Regatieri</surname><given-names>CV</given-names></name>
<name><surname>Campos</surname><given-names>M</given-names></name>
<etal/>
</person-group>
<article-title>Centration in refractive surgery</article-title>
<source>Arq Bras Oftalmol</source>
<year>2020</year>
<volume>83</volume>
<issue>1</issue>
<fpage>76</fpage>
<lpage>81</lpage>
</element-citation>
<mixed-citation>Rios LC, Silva PG, Canamary Júnior AM, Rodrigues P, Regatieri CV, Campos M, et al. Centration in refractive surgery. Arq Bras Oftalmol. 2020;83(1):76-81.</mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rodrigues</surname><given-names>PF</given-names></name>
<name><surname>Moscovici</surname><given-names>BK</given-names></name>
<name><surname>Lamazales</surname><given-names>L</given-names></name>
<name><surname>Freitas</surname><given-names>MM</given-names></name>
<name><surname>Gomes</surname><given-names>JA</given-names></name>
<name><surname>Nosé</surname><given-names>W</given-names></name>
<etal/>
</person-group>
<article-title>Measurement of the visual axis through two different methods: quantification and differences for measuring chord μ</article-title>
<source>Arq Bras Oftalmol</source>
<year>2023</year>
<comment>S0004-27492023005002305</comment>
</element-citation>
<mixed-citation>Rodrigues PF, Moscovici BK, Lamazales L, Freitas MM, Gomes JA, Nosé W, et al. Measurement of the visual axis through two different methods: quantification and differences for measuring chord μ. Arq Bras Oftalmol. 2023:S0004-27492023005002305.</mixed-citation>
</ref>
<ref id="B10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Miranda</surname><given-names>AP</given-names></name>
<name><surname>Silva</surname><given-names>CB</given-names></name>
<name><surname>Mimica</surname><given-names>LM</given-names></name>
<name><surname>Moscovici</surname><given-names>BK</given-names></name>
<name><surname>Malavazzi</surname><given-names>GR</given-names></name>
<name><surname>Hida</surname><given-names>RY</given-names></name>
</person-group>
<article-title>In vitro antimicrobial analysis of aqueous humor after topical application of moxifloxacin hydrochloride 0.5%</article-title>
<source>J Cataract Refract Surg</source>
<year>2015</year>
<volume>41</volume>
<issue>1</issue>
<fpage>135</fpage>
<lpage>139</lpage>
</element-citation>
<mixed-citation>Miranda AP, Silva CB, Mimica LM, Moscovici BK, Malavazzi GR, Hida RY. In vitro antimicrobial analysis of aqueous humor after topical application of moxifloxacin hydrochloride 0.5%. J Cataract Refract Surg. 2015;41(1):135-9.</mixed-citation>
</ref>
</ref-list>
</back>
</article>
